Related Experiment Video
Updated: Jul 9, 2025

14:38
Preparation, Procedures and Evaluation of Platelet-Rich Plasma Injection in the Treatment of Knee Osteoarthritis
Published on: January 4, 2019
18.3K
Current Status and Advancements in Platelet-Rich Plasma Therapy
Jacques Pretorius1, Mohammed Habash2, Bishoy Ghobrial1
1Trauma and Orthopaedics, University Hospital Galway, Galway, IRL.
Cureus
|November 29, 2023
Summary
Platelet-rich plasma (PRP) therapy is increasingly popular for musculoskeletal issues, with evidence supporting its use in conditions like osteoarthritis but showing mixed results for tendinopathies.
Area of Science:
- Orthopedics
- Regenerative Medicine
- Sports Medicine
Background:
- Platelet-rich plasma (PRP) has emerged as a significant therapeutic modality over the past 10-15 years.
- Its application spans various medical fields, with a notable focus on regenerative medicine and infertility treatments.
- Musculoskeletal conditions represent a primary area of research and clinical application for PRP.
Purpose of the Study:
- To review the current evidence and applications of Platelet-rich plasma (PRP) in treating musculoskeletal conditions.
- To highlight the areas where PRP has demonstrated efficacy and where research is still limited or conflicting.
Main Methods:
- A review of existing literature and level I evidence regarding the use of PRP in musculoskeletal conditions.
- Analysis of research focusing on specific conditions such as osteoarthritis, tendinopathies, and other soft tissue injuries.
Main Results:
- Level I evidence supports PRP efficacy in osteoarthritis, epicondylitis, bursitis, compressive neuropathy, plantar fasciitis, muscular injuries, and osteochondral lesions.
- Research is most concentrated on knee osteoarthritis and lateral epicondylitis, with less data on spinal and hand conditions.
- Conflicting level I evidence exists for tendinopathies and partial tendon tears, with support for rotator cuff but not consistently for patellar or Achilles injuries.
Conclusions:
- Despite conflicting evidence in certain conditions like tendinopathies, the use and popularity of PRP for musculoskeletal issues continue to rise.
- Further research is needed to clarify PRP's role in specific tendinopathies and other less-studied musculoskeletal conditions.
- PRP remains a widely adopted treatment modality in orthopedics and sports medicine for a range of ailments.
Related Concept Videos
Formation of the Platelet Plug
6.4K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.4K
Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
Clot Retraction and Fibrinolysis
6.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.2K

